Sumitomo Pharma Co., Ltd. (DNPUF)
OTCMKTS · Delayed Price · Currency is USD
14.36
-2.38 (-14.19%)
At close: Dec 12, 2025
Sumitomo Pharma Market Cap
Sumitomo Pharma has a market cap or net worth of $6.68 billion as of January 7, 2026. Its market cap has increased by 339.87% in one year.
Market Cap
6.68B
Enterprise Value
8.11B
Revenue
3.01B
Ranking
n/a
PE Ratio
6.39
Stock Price
$14.36
Market Cap Chart
Since January 14, 1992, Sumitomo Pharma's market cap has increased from 1.62B to 6.68B, an increase of 311.09%. That is a compound annual growth rate of 4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 6.65B | 12.86% |
| Dec 30, 2025 | 5.89B | 314.07% |
| Dec 30, 2024 | 1.42B | 8.36% |
| Dec 29, 2023 | 1.31B | -56.36% |
| Dec 30, 2022 | 3.01B | -34.17% |
| Dec 30, 2021 | 4.57B | -21.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 781.81M |
| Glass House Brands | 714.29M |
| Elite Pharmaceuticals | 516.25M |
| Northwest Biotherapeutics | 499.37M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 368.24M |
| Silence Therapeutics | 280.10M |